Biotech News
Related news
BDSXBiodesix2026-08-04 10:00 EST
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
AVTXAvalo Therapeutics2026-07-22 11:00 EST
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
KYMRKymera2026-05-27 11:00 EST
Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
CLDXCelldex Therapeutics2026-06-10 20:01 EST
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
ACRSAclaris Therapeutics2026-05-28 12:30 EST
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
BMYBMYBristol-Myers Squibb Company2026-05-27 10:59 EST
Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
NRIXNurix Therapeutics2026-05-12 20:05 EST
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
XGNExagen2026-07-21 13:00 EST
Exagen to Announce Second Quarter Financial Results on August 4, 2026
ENTAEnanta Pharmaceuticals2026-05-28 11:00 EST
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Exagen
Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...
Recent company news
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
XGNExagen2026-07-21 13:00 EST
Exagen to Announce Second Quarter Financial Results on August 4, 2026
XGNExagen2026-06-01 13:00 EST
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
XGNExagen2026-05-11 12:00 EST
Exagen Inc. Reports First Quarter 2026 Results
Stock data
- Close
- 6.59 USD
- Market cap
- 116.45M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States